Exploring the next generation of antibody–drug conjugates
Antibody–drug conjugates (ADCs) are a promising cancer treatment modality that enables
the selective delivery of highly cytotoxic payloads to tumours. However, realizing the full …
the selective delivery of highly cytotoxic payloads to tumours. However, realizing the full …
Exploring the next generation of antibody-drug conjugates.
K Tsuchikama, Y Anami, SYY Ha… - Nature reviews. Clinical …, 2024 - europepmc.org
Antibody-drug conjugates (ADCs) are a promising cancer treatment modality that enables
the selective delivery of highly cytotoxic payloads to tumours. However, realizing the full …
the selective delivery of highly cytotoxic payloads to tumours. However, realizing the full …
Exploring the next generation of antibody-drug conjugates
K Tsuchikama, Y Anami, SYY Ha… - Nature reviews … - pubmed.ncbi.nlm.nih.gov
Antibody-drug conjugates (ADCs) are a promising cancer treatment modality that enables
the selective delivery of highly cytotoxic payloads to tumours. However, realizing the full …
the selective delivery of highly cytotoxic payloads to tumours. However, realizing the full …